Literature DB >> 22463921

High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts.

Hao Ou-Yang1, Joseph Stanfield, Curtis Cole, Yohini Appa, Darrell Rigel.   

Abstract

BACKGROUND: The manner in which consumers apply sunscreens is often inadequate for ultraviolet protection according to the labeled sun protection factor (SPF). Although sunscreen SPFs are labeled by testing at an application density of 2 mg/cm(2), the actual protection received is often substantially less because of consumer application densities ranging from 0.5 to 1 mg/cm(2). High-SPF sunscreens may provide more adequate protection even when applied by consumers at inadequate amounts.
OBJECTIVE: We sought to measure the actual SPF values of various sunscreens (labeled SPF 30-100) applied in amounts typical of those used by consumers.
METHODS: Actual SPF values were measured on human volunteers for 6 sunscreen products with labeled SPF values ranging from 30 to 100, applied at 0.5, 1.0, 1.5, and 2.0 mg/cm(2).
RESULTS: There was a linear relationship between application density and the actual SPF; sunscreens with labeled SPF values of 70 and above provided significant protection, even at the low application densities typically applied by consumers. Sunscreens labeled SPF 70 and 100 applied at 0.5 mg/cm(2) provided an actual SPF value of, respectively, 19 and 27. LIMITATIONS: The study was conducted in a laboratory setting under standardized conditions and results are extrapolated to actual in-use situations.
CONCLUSION: Sunscreens with SPF 70 and above add additional clinical benefits when applied by consumers at typically used amounts, by delivering an actual SPF that meets the minimum SPF levels recommended for skin cancer and photodamage prevention. In contrast, sunscreens with SPF 30 or 50 may not produce sufficient protection at actual consumer usage levels.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22463921     DOI: 10.1016/j.jaad.2012.02.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  [Sun protection factor 50+ : Pro and contra].

Authors:  T Herzinger
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

Review 2.  [New approaches for the prevention of actinic keratosis].

Authors:  H Stege; J Krutmann
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

Review 3.  [Sunscreens of the future: challenges and opportunities].

Authors:  Peter Wolf; Jean Krutmann
Journal:  Hautarzt       Date:  2022-03-08       Impact factor: 0.751

4.  The UVR Filter Octinoxate Modulates Aryl Hydrocarbon Receptor Signaling in Keratinocytes via Inhibition of CYP1A1 and CYP1B1.

Authors:  Sarah J Phelan-Dickinson; Brian C Palmer; Yue Chen; Lisa A DeLouise
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

5.  Development of the multispectral UV polarization reflectance imaging system (MUPRIS) for in situ monitoring of the UV protection efficacy of sunscreen on human skin.

Authors:  Ken Nishino; Yasushi Haryu; Ayui Kinoshita; Shigeki Nakauchi
Journal:  Skin Res Technol       Date:  2019-03-19       Impact factor: 2.365

6.  Anti-inflammatory / anti-oxidant activity of ingredients of sunscreen products? Implications for SPF.

Authors:  L Kolbe; M Pissavini; C Tricaud; C Trullás Cabanas; E Dietrich; P J Matts
Journal:  Int J Cosmet Sci       Date:  2019-06       Impact factor: 2.970

7.  Potential allergenicity of commonly sold high SPF broad spectrum sunscreens in the United States; from the perspective of patients with autoimmune skin disease.

Authors:  Emily Keyes; Victoria P Werth; Bruce Brod
Journal:  Int J Womens Dermatol       Date:  2019-05-23

8.  Physical Determinants of Vitamin D Photosynthesis: A Review.

Authors:  Jonathan J Neville; Tommaso Palmieri; Antony R Young
Journal:  JBMR Plus       Date:  2021-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.